Evidence map›Paper›PMID 27067081›Full record

ArticlePediatric nephrology (Berlin, Germany)2016

Desmopressin (melt) therapy in children with monosymptomatic nocturnal enuresis and nocturnal polyuria results in improved neuropsychological functioning and sleep.

Charlotte Van Herzeele, Karlien Dhondt, Sanne P Roels, Ann Raes, Piet Hoebeke, Luitzen-Albert Groen, Johan Vande Walle

Abstract read
PubMed Publisher
In one paragraph

Article in Pediatric nephrology (Berlin, Germany), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
3.9field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Pathogenesis and brain functional imaging in nocturnal enuresis: A review.Experimental biology and medicine (Maywood, N.J.) · 2021
    Review
  5. Observational
  6. Article
  7. Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Charlotte Van HerzeeleDepartment of Pediatric Nephrology/Urology and Safepedrug, University Hospital Ghent and Ghent University, De Pintelaan 185, 9000, Ghent, Belgium. charlotte.vanherzeele@ugent.be.
Karlien DhondtChild Neurology & Metabolism, Pediatric Sleep Center, University Hospital Ghent, Ghent, Belgium.
Sanne P RoelsDepartment of Data Analysis, University Ghent, Ghent, Belgium.
Ann RaesDepartment of Pediatric Nephrology/Urology and Safepedrug, University Hospital Ghent and Ghent University, De Pintelaan 185, 9000, Ghent, Belgium.
Piet HoebekeDepartment of Pediatric Nephrology/Urology and Safepedrug, University Hospital Ghent and Ghent University, De Pintelaan 185, 9000, Ghent, Belgium.
Luitzen-Albert GroenDepartment of Pediatric Nephrology/Urology and Safepedrug, University Hospital Ghent and Ghent University, De Pintelaan 185, 9000, Ghent, Belgium.
Johan Vande WalleDepartment of Pediatric Nephrology/Urology and Safepedrug, University Hospital Ghent and Ghent University, De Pintelaan 185, 9000, Ghent, Belgium.
Ghent University Hospital · BEGhent University · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThere is a high comorbidity between nocturnal enuresis, sleep disorders and psychological problems. The aim of this study was to investigate whether a decrease in nocturnal diuresis volume not only improves enuresis but also ameliorates disrupted sleep and (neuro)psychological dysfunction, the major comorbidities of this disorder.

methodsIn this open-label, prospective phase IV study, 30 children with monosymptomatic nocturnal enuresis (MNE) underwent standardized video-polysomnographic testing and multi-informant (neuro)psychological testing at baseline and 6 months after the start of desmopressin treatment in the University Hospital Ghent, Belgium. Primary endpoints were the effect on sleep and (neuro)psychological functioning. The secondary endpoint was the change in the first undisturbed sleep period or the time to the first void.

resultsThirty children aged between 6 and 16 (mean 10.43, standard deviation 3.08) years completed the study. The results demonstrated a significant decrease in periodic limb movements during sleep (PLMS) and a prolonged first undisturbed sleep period. Additionally, (neuro)psychological functioning was improved on several domains.

conclusionsThe study demonstrates that the degree of comorbidity symptoms is at least aggravated by enuresis (and/or high nocturnal diuresis rate) since sleep and (neuro)psychological functioning were significantly ameliorated by treatment of enuresis. These results indicate that enuresis is not such a benign condition as has previously been assumed.

Indexed as

ChildDeamino Arginine VasopressinHumansNocturnal EnuresisPolyuriaProspective StudiesDeamino Arginine VasopressinChildrenDesmopressinPeriodic limb movementsPsychologyQuality of life

Identifiers

PMID27067081
OpenAlexW2339632069

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.